Nuremberg, Germany (ots) - With effect from 31 July 2003, the GfK Group will acquire a stake of 51 per cent in pharma market research specialists V2 in Pennsylvania, USA. This acquisition grants GfK access to the most important market for information services relating to pharmaceuticals, biotechnology and medical ...
Madrid (ots) - New data from the VIM study presented today at the annual Congress of the European Society of Ophthalmology (SOE) demonstrate that Visudyne® therapy benefited patients with smaller base line lesions* in minimally classic "wet" AMD, a form of AMD previously considered untreatable.1 Visudyne is the ...
Leverkusen (ots) - The U.S. Food and Drug Administration (FDA) has approved Bayer's antibiotic product Cipro(R) XR (Ciprofloxacin Extended-Release Tablets). This new formulation, given once a day over three days, is designed to treat uncomplicated urinary tract infections (UTIs). Cipro(R) XR will be marketed in a ...
Basel (ots) - Biopharmaceutical company Actelion has become the newest member of Interpharma, the Association of Pharmaceutical Research Companies of Switzerland. Headquartered in Allschwil, canton Baselland, Actelion was accepted as an associate member at Interpharma's most recent general assembly. Associate member status gives Actelion a seat on the expanded Executive Board and on all of the association's task ...
Basel (ots) - * First-quarter Group sales up 13% in local currencies (10% in Swiss francs) * Pharmaceuticals extends double-digit sales growth (+16% in local currencies; +14% in Swiss francs), driven by strong demand for cardiovascular, oncology and ophthalmic products in all regions * Net profits surge ...
Basel, Switzerland (ots) - Biomit Inc., a strategic e-clinical research partner for the biopharmaceutical industry, continues to establish offices throughout Europe as it expands its integrated worldwide representation. Today marks the official opening of its office in Heidelberg, which will coordinate on-line, ...